Beit Jala Pharmaceutical Company (PEX:BJP)
Palestine flag Palestine · Delayed Price · Currency is JOD
3.620
+0.020 (0.56%)
At close: Jan 13, 2026

PEX:BJP Income Statement

Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
12.059.669.6110.779.768.69
Revenue Growth (YoY)
32.68%0.54%-10.73%10.37%12.26%-1.41%
Cost of Revenue
7.386.486.156.756.966.12
Gross Profit
4.673.193.464.022.792.57
Selling, General & Admin
1.421.261.31.661.691.52
Operating Expenses
1.421.261.31.661.691.52
Operating Income
3.261.922.162.351.111.05
Interest Expense
-0.08-0.11-0.11-0.12-0.09-0.07
Currency Exchange Gain (Loss)
-0.180.06-0.10.120.03-0.11
Other Non Operating Income (Expenses)
-0.02-0.010.010.010.01
Pretax Income
2.981.871.962.361.050.88
Income Tax Expense
0.260.120.120.380.180.14
Net Income
2.721.761.841.980.870.75
Net Income to Common
2.741.761.841.980.870.75
Net Income Growth
112.01%-4.42%-7.26%127.43%16.87%-45.33%
Shares Outstanding (Basic)
777777
Shares Outstanding (Diluted)
777777
EPS (Basic)
0.390.250.260.280.120.11
EPS (Diluted)
0.390.250.260.280.120.11
EPS Growth
113.54%-4.42%-7.26%127.43%16.87%-45.33%
Free Cash Flow
1.680.220.672.810.27-0.1
Free Cash Flow Per Share
0.240.030.100.400.04-0.01
Dividend Per Share
0.1200.1200.1000.1000.1000.100
Dividend Growth
20.00%20.00%----33.33%
Gross Margin
38.78%32.99%36.00%37.31%28.63%29.60%
Operating Margin
27.03%19.91%22.45%21.87%11.35%12.12%
Profit Margin
22.71%18.17%19.11%18.40%8.93%8.58%
Free Cash Flow Margin
13.97%2.26%6.97%26.14%2.75%-1.11%
EBITDA
5.712.63.263.312.121.98
EBITDA Margin
47.34%26.95%33.90%30.70%21.69%22.77%
D&A For EBITDA
2.450.681.10.951.010.93
EBIT
3.261.922.162.351.111.05
EBIT Margin
27.03%19.91%22.45%21.87%11.35%12.12%
Effective Tax Rate
8.78%6.18%6.29%16.22%17.21%15.49%
Advertising Expenses
-0.030.040.080.070.07
Source: S&P Global Market Intelligence. Standard template. Financial Sources.